· Current Price – $0.0419
· Best Case Scenario PT over 1$
· Market Cap – $11 million
· Debt – 0
Halbert Corporation
Are a biomedical company with a clear aim to revolutionize the world of medicine. They are working towards a creation of variety of antibodies and treatments using extracorporeal techniques (outside of body). They believe they have the...
HALB is positioned as an alternative to traditional vaccine solutions, which is a rare narrative, potentially conferring scarcity value on shares (contingent on efficacy and execution.
The company that holds the exclusive rights to a number of COVID-19 “extracorporeal treatment” technology provisional patent applications ("Method for Treating and Curing Covid-19...
